You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

treatment-free remission

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Treatment-free Remission
  • TFR(Treatment-Free Remission)
  • (no location specified)
Jun 27, 2022

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

Not yet recruiting
  • Chronic Myeloid Leukemia, BCR/ABL-Positive
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jul 24, 2022

    Treatment Free Remission, Chronic Myeloid Leukemia Trial in Turin

    Recruiting
    • Treatment Free Remission
    • Chronic Myeloid Leukemia
      • Turin, Italy
        Division of Hematology-AO Mauriziano Hospital, University of Tur
      Nov 17, 2021

      Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia
      • Detroit, Michigan
      • +1 more
      May 3, 2022

      Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

      Not yet recruiting
      • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
      • (no location specified)
      Jun 7, 2022

      Outcomes of Tyrosine Kinase Inhibitor(TKI)Stopping in Chronic

      Recruiting
      • Folate
      • +2 more
        • Nantong, China
          Affliated Hospital of Nantong University
        Dec 13, 2021

        Acute Myeloid Leukemia Trial in Houston (Decitabine and Cedazuridine, Enasidenib, Gilteritinib)

        Recruiting
        • Acute Myeloid Leukemia
        • Decitabine and Cedazuridine
        • +4 more
        • Houston, Texas
          M D Anderson Cancer Center
        Aug 10, 2022

        Chronic Myeloid Leukemia Trial in Worldwide (nilotinib)

        Active, not recruiting
        Has Results
        • Chronic Myeloid Leukemia
        • Los Angeles, California
        • +61 more
        Mar 17, 2022

        Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic

        Withdrawn
        • CLL
        • +4 more
        • Treatment Free Observation
        • Basking Ridge, New Jersey
        • +8 more
        Mar 4, 2022

        Leukemia, Chronic Myeloid Trial in Campinas (Pioglitazone, imatinib discontinuation)

        Active, not recruiting
        • Leukemia, Chronic Myeloid
        • Campinas, SP, Brazil
          Centro de Hematologia e Hemoterapia - Universidade Estadual de C
        Nov 2, 2020

        Chronic Myelogenous Leukemia Trial in Worldwide (Nilotinib followed by treatment-free)

        Active, not recruiting
        Has Results
        • Chronic Myelogenous Leukemia
        • Nilotinib followed by treatment-free
        • Fort Myers, Florida
        • +113 more
        Apr 25, 2022

        Progression Free Survival, Overall Survival, Maintenance Trial (Ixazomib DX/Lenalidomide DX)

        Not yet recruiting
        • Progression Free Survival
        • +2 more
        • Ixazomib DX/Lenalidomide DX
        • (no location specified)
        Jul 27, 2022

        Dissecting Cellular and Molecular Atlas of Rheumatoid Arthritis

        Recruiting
        • Rheumatoid Arthritis
        • Tapering and/or discontinuation of treatment based on AI-guidance
        • +3 more
        • Rome, Italy
        • +3 more
        Jul 20, 2023

        ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)

        Recruiting
        • ANCA-associated Vasculitis
        • Maintenance Therapy
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Jul 20, 2023

        Asthma Trial (Mepolizumab, Spirometry)

        Not yet recruiting
        • Asthma
        • (no location specified)
        Sep 15, 2023

        Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)

        Not yet recruiting
        • Diffuse Large B-cell Lymphoma
        • Mitoxantrone hydrochloride liposome injection
        • +4 more
        • Changchun, Jilin, China
          The First Bethune Hospital of Jilin University
        Aug 15, 2023

        Rheumatoid Arthritis Trial (Treatment target DAS28CRP-LDA, Treatment target SDAI-remission)

        Not yet recruiting
        • Rheumatoid Arthritis
        • Treatment target DAS28CRP-LDA
        • Treatment target SDAI-remission
        • (no location specified)
        Sep 13, 2023

        Development of Minimally Invasive Methodology for Diabetyping to

        Not yet recruiting
        • Type 2 Diabetes
          • (no location specified)
          Nov 3, 2023

          3TR Asthma Biologics Cohort (ABC) Study

          Recruiting
          • Severe Asthma
            • Copenhagen, Denmark
            • +1 more
            Nov 6, 2023

            Autoimmune Diseases Trial in Beijing (, mycophenolate mofetil)

            Not yet recruiting
            • Autoimmune Diseases
            • placebo
            • mycophenolate mofetil
            • Beijing, China
              Peking Union Medical College Hospital
            Jul 26, 2023

            Schizophrenia Trial in Taichung (NMDAE, Placebo Cap)

            Not yet recruiting
            • Schizophrenia
            • Taichung, Taiwan
              Department of Psychiatry, China Medical University Hospital
            Sep 4, 2023

            3TR Systemic Lupus Erythematosus Study Protocol 2

            Not yet recruiting
            • Systemic Lupus Erythematosus (SLE)
            • Blood sample
            • +4 more
            • (no location specified)
            Feb 17, 2023

            Ulcerative Colitis, Ulcerative Colitis Chronic Mild, Ulcerative Colitis Chronic Moderate Trial in Worldwide (Ulcerative colitis

            Not yet recruiting
            • Ulcerative Colitis
            • +2 more
            • Ulcerative colitis Exclusion Diet
            • +3 more
            • Afula, Israel
            • +5 more
            Mar 16, 2023

            Remission WithVery Low-calorie Ketogenic Diet and Lifestyle

            Recruiting
            • Type 2 Diabetes Mellitus
            • Overweight and Obesity
            • VLCKD
            • Lausanne, Switzerland
              Dr. Daniela Sofra
            Aug 2, 2023